Moody's may cut Sanofi-Aventis on Genzyme offer
SAN FRANCISCO (MarketWatch) — Moody's Investors Service said Monday it may downgrade the ratings of Sanofi-Aventis SA (NYSE:SNY) by one notch over its tender offer for Genzyme Corp. (NASDAQ:GENZ) . Moody's has an A1 issuer and senior unsecured
Health giant Sanofi-Aventis launches bid for Genzyme AFP

Sanofi-Aventis Launches Genzyme Takeover Battle WJAC Johnstown
Sanofi Turns Hostile In Bid For Genzyme Worcester Business Journal
Reuters -AHN | All Headline News -Xconomy
all 854 news articles »



Post a Comment
* Your Name:

* Your Email:

(NEVER publicly displayed)
Website URL:
* Security Image:
Security Image Generate New
Copy the numbers and letters from the security image:
* Your Comment:
No HTML tags are permitted in comments.
By submitting, you agree with our Publishing Policy. Please note that we may publish your comment in other sections of this site.